Although previous studies have linked decreased SFXN1 expression in the brain to Alzheimer's disease and Parkinson's disease, and SFXN1 downregulation has been associated with nonviral hepatocellular carcinoma [26, 27, 28], the role of SFXN1 in neuronal death remains unclear. This evidence concerns the gene SFXN1 and Alzheimer disease.